不适合移植的大 B 细胞淋巴瘤二线使用 axicabtagene ciloleucel:ALYCANTE 最终分析
Second-line axicabtagene ciloleucel in large B-cell lymphoma ineligible for transplantation: ALYCANTE final analysis.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Extranodal NK/T-cell lymphoma primarily presenting as two adjacent slowly growing skin nodules with prominent epidermotropism and CD30 expression, a case report and review of literature.
Extranodal NK/T-cell lymphoma primarily presenting as two adjacent slowly growing skin nodules with prominent epidermotropism and CD30 expression, a case report and review of literature.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
结外NK/T细胞淋巴瘤(NKTCL)是一种罕见的非霍奇金淋巴瘤,好发于鼻腔。皮肤受累较少见,且通常侵袭性较强,可表现为结节或肿块,有时伴溃疡。组织学上,病灶表现为非典型真皮淋巴细胞浸润,伴血管侵犯及相关坏死。幸运的是,与该病发病机制有关的EB病毒感染可作为有用的诊断标志物,例如通过EBER原位杂交检测。本文报告一名54岁男性,起初右小腿出现两处溃疡,经抗生素治疗后仍进展。组织学检查显示密集淋巴细胞浸润,具有表皮趋向性、血管中心性和血管侵犯,并延伸至深层真皮。免疫组化显示CD2、CD3、CD8、TIA-1、穿孔素和颗粒酶B表达,符合细胞毒性T细胞表型;此外CD56阳性,证实同时存在NK细胞表型。检测还发现显著CD30表达,分子分析显示TCR基因重排阳性。结合EBER原位杂交阳性,最终确诊为结外NKTCL。本文旨在提高对这种罕见皮肤受累淋巴瘤的认识。NKTCL表达CD30提示,可考虑使用brentuximab进行靶向治疗。
Extranodal NK/T-cell lymphoma (NKTCL) is a rarely occurring non-Hodgkin lymphoma with predilection for the nasal cavity. Cutaneous involvement, rarely occurring and often aggressive in behavior, may present as nodular mass-forming lesions with or without ulceration.
Histologically, lesions are characterized by an atypical dermal lymphoid infiltrate with angioinvasion and associated necrosis. Fortuitously, Epstein-Barr virus (EBV) infection, implicated in the pathogenesis of this entity, serves as a useful diagnostic marker (i. e. EBER in situ hybridization).
We present a 54-year-old-man who initially presented with two ulcerations on the right lower leg which progressed despite antibiotic therapy. Histologic examination demonstrated dense lymphoid infiltrates exhibiting epidermotropism, angiocentricity and angioinvasion extending into the deep dermis. Immunohistochemical staining demonstrated expression of CD2, CD3, CD8, TIA-1, perforin, and granzyme-B, consistent with a cytotoxic T-cell phenotype.
Additionally, CD56 was positive, confirming the presence of a coexistent NK cell phenotype. Testing also demonstrated significant CD30 expression, and molecular analysis was positive for TCR gene rearrangement.
These findings, in conjunction with EBER in situ hybridization positivity, confirmed a diagnosis of extranodal NKTCL.
We aim to increase awareness of this rarely occurring lymphoma with cutaneous involvement. CD30 expression in NKTCL raises the possibility of targeted treatment with brentuximab.
MEMBER ACCOUNT
登录成功会直接打开下一页。